High Plasma Fibronectin Levels in Multiple Myeloma Patients: Possible Mechanisms and Clinical Implications
- 1 September 1991
- journal article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 34 (3) , 285-289
- https://doi.org/10.1111/j.1365-3083.1991.tb01548.x
Abstract
Fibronectin (FN) has been implicated in the formation of cryoprecipitates in rheumatic diseases and is present in tissues where, under pathological conditions, immune complexes are frequently deposited. We found elevated levels of FN in the plasma of 92% of multiple myeloma patients tested compared with a group of normal subjects, although the level of FN did not correlate with the level of the paraprotein. We then characterized the interacting fragments on both molecules and found that under physiological conditions of pH and ionic strength both heavy and light chain of all multiple myeloma and normal IgG showed affinity to FN; the active fragment on FN was found to be the aminoterminal heparin-binding domain. These findings raise the possibility that FN might be implicated in some of the clinical symptoms of multiple myeloma.Keywords
This publication has 6 references indexed in Scilit:
- Elution of fibronectin proteolytic fragments from a hydroxyapatite chromatography column. A simple procedure for the purification of fibronectin domainsEuropean Journal of Biochemistry, 1985
- Plasma fibronectin as a marker for cancer and other diseasesThe American Journal of Medicine, 1984
- Fibronectin concentration in plasma of patients with breast cancer, colon cancer, and acute leukemiaCancer, 1983
- The Influence of Fibronectin on Cryoprecipitate Formation in Rheumatoid Arthritis and Systemic Lupus ErythematosusArthritis & Rheumatism, 1981
- Humoral mediated macrophage response during tumour growthBritish Journal of Cancer, 1975
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970